AAPL337.02-2.73 (-0.80%) ▼|ABBV265.08-0.13 (-0.05%) ▼|ABT103.49-0.20 (-0.19%) ▼|ACN183.52-0.20 (-0.11%) ▼|ADBE240.69+2.44 (+1.02%) ▲|AMAT474.38+1.92 (+0.41%) ▲|AMD614.61-9.16 (-1.47%) ▼|AMGN406.09-4.15 (-1.01%) ▼|AMT170.78-4.47 (-2.55%) ▼|AMZN249.27-5.71 (-2.24%) ▼|AVGO354.99-9.55 (-2.62%) ▼|AXP301.96-3.11 (-1.02%) ▼|BA199.93+2.21 (+1.12%) ▲|BAC56.00-0.20 (-0.36%) ▼|BKNG155.90-8.32 (-5.07%) ▼|BLK1,060.89-5.77 (-0.54%) ▼|BMY61.15-1.10 (-1.77%) ▼|BNY149.51-0.66 (-0.44%) ▼|BRK-B507.17+3.68 (+0.73%) ▲|C131.93-0.54 (-0.41%) ▼|CAT812.02+4.01 (+0.50%) ▲|CL85.93-1.12 (-1.29%) ▼|CMCSA22.55+0.13 (+0.58%) ▲|COF196.10-4.45 (-2.22%) ▼|COP128.09+2.82 (+2.25%) ▲|COST904.70+5.29 (+0.59%) ▲|CRM237.58+4.30 (+1.84%) ▲|CSCO106.43-0.01 (-0.01%) ▼|CVS85.86-1.24 (-1.42%) ▼|CVX205.51+3.10 (+1.53%) ▲|DE709.48+6.36 (+0.90%) ▲|DHR221.56+0.47 (+0.21%) ▲|DIS103.46-0.36 (-0.35%) ▼|DUK114.17-2.14 (-1.84%) ▼|EMR154.59+0.40 (+0.26%) ▲|FDX291.50-4.44 (-1.50%) ▼|GD343.33-0.06 (-0.02%) ▼|GE319.80+0.58 (+0.18%) ▲|GEV951.82+1.54 (+0.16%) ▲|GILD151.37-1.30 (-0.85%) ▼|GM83.77+0.32 (+0.38%) ▲|GOOG334.98-12.43 (-3.58%) ▼|GOOGL337.83-13.33 (-3.80%) ▼|GS936.36-13.13 (-1.38%) ▼|HD296.72-8.63 (-2.83%) ▼|HON212.57+0.72 (+0.34%) ▲|IBM232.76+1.38 (+0.60%) ▲|INTC122.60-1.26 (-1.02%) ▼|INTU286.80-5.55 (-1.90%) ▼|ISRG398.30-3.79 (-0.94%) ▼|JNJ269.17-0.02 (-0.01%) ▼|JPM337.53-2.47 (-0.73%) ▼|KO88.09-0.52 (-0.59%) ▼|LIN469.72+4.81 (+1.03%) ▲|LLY1,150.99-19.15 (-1.64%) ▼|LMT524.68+2.34 (+0.45%) ▲|LOW191.36-4.72 (-2.41%) ▼|LRCX307.28-3.35 (-1.08%) ▼|MA559.92+4.03 (+0.73%) ▲|MCD238.32-12.03 (-4.81%) ▼|MDLZ61.44+0.36 (+0.59%) ▲|MDT89.30-1.47 (-1.62%) ▼|META744.10+7.51 (+1.02%) ▲|MMM170.30+1.00 (+0.59%) ▲|MO68.95+0.31 (+0.45%) ▲|MRK148.08-2.83 (-1.88%) ▼|MS198.39-1.79 (-0.89%) ▼|MSFT500.59+2.59 (+0.52%) ▲|MU1,071.88-24.28 (-2.22%) ▼|NEE77.02-2.24 (-2.83%) ▼|NFLX71.36-0.80 (-1.11%) ▼|NKE36.05-0.05 (-0.14%) ▼|NOW140.78+3.78 (+2.76%) ▲|NVDA225.51-3.36 (-1.47%) ▼|ORCL144.56-4.64 (-3.11%) ▼|PEP130.18-1.01 (-0.77%) ▼|PFE28.18+0.25 (+0.90%) ▲|PG147.39-0.83 (-0.56%) ▼|PLTR191.79+6.80 (+3.68%) ▲|PM190.84+0.61 (+0.32%) ▲|QCOM197.24-1.03 (-0.52%) ▼|RTX192.19+1.20 (+0.63%) ▲|SBUX94.14-0.97 (-1.02%) ▼|SCHW99.50-0.85 (-0.85%) ▼|SO83.47-1.68 (-1.97%) ▼|SPG204.16-1.79 (-0.87%) ▼|T25.30+0.20 (+0.80%) ▲|TMO665.30+6.78 (+1.03%) ▲|TMUS165.66+3.25 (+2.00%) ▲|TSLA380.12+1.22 (+0.32%) ▲|TXN272.62+1.21 (+0.45%) ▲|UBER69.42-0.47 (-0.67%) ▼|UNH371.29-1.66 (-0.45%) ▼|UNP275.53+1.12 (+0.41%) ▲|UPS95.82-0.05 (-0.05%) ▼|USB58.48-0.96 (-1.62%) ▼|V361.52-0.52 (-0.14%) ▼|VZ46.52+0.07 (+0.15%) ▲|WFC81.90-1.25 (-1.50%) ▼|WMT110.53+0.41 (+0.37%) ▲|XOM161.23+2.52 (+1.59%) ▲|AAPL337.02-2.73 (-0.80%) ▼|ABBV265.08-0.13 (-0.05%) ▼|ABT103.49-0.20 (-0.19%) ▼|ACN183.52-0.20 (-0.11%) ▼|ADBE240.69+2.44 (+1.02%) ▲|AMAT474.38+1.92 (+0.41%) ▲|AMD614.61-9.16 (-1.47%) ▼|AMGN406.09-4.15 (-1.01%) ▼|AMT170.78-4.47 (-2.55%) ▼|AMZN249.27-5.71 (-2.24%) ▼|AVGO354.99-9.55 (-2.62%) ▼|AXP301.96-3.11 (-1.02%) ▼|BA199.93+2.21 (+1.12%) ▲|BAC56.00-0.20 (-0.36%) ▼|BKNG155.90-8.32 (-5.07%) ▼|BLK1,060.89-5.77 (-0.54%) ▼|BMY61.15-1.10 (-1.77%) ▼|BNY149.51-0.66 (-0.44%) ▼|BRK-B507.17+3.68 (+0.73%) ▲|C131.93-0.54 (-0.41%) ▼|CAT812.02+4.01 (+0.50%) ▲|CL85.93-1.12 (-1.29%) ▼|CMCSA22.55+0.13 (+0.58%) ▲|COF196.10-4.45 (-2.22%) ▼|COP128.09+2.82 (+2.25%) ▲|COST904.70+5.29 (+0.59%) ▲|CRM237.58+4.30 (+1.84%) ▲|CSCO106.43-0.01 (-0.01%) ▼|CVS85.86-1.24 (-1.42%) ▼|CVX205.51+3.10 (+1.53%) ▲|DE709.48+6.36 (+0.90%) ▲|DHR221.56+0.47 (+0.21%) ▲|DIS103.46-0.36 (-0.35%) ▼|DUK114.17-2.14 (-1.84%) ▼|EMR154.59+0.40 (+0.26%) ▲|FDX291.50-4.44 (-1.50%) ▼|GD343.33-0.06 (-0.02%) ▼|GE319.80+0.58 (+0.18%) ▲|GEV951.82+1.54 (+0.16%) ▲|GILD151.37-1.30 (-0.85%) ▼|GM83.77+0.32 (+0.38%) ▲|GOOG334.98-12.43 (-3.58%) ▼|GOOGL337.83-13.33 (-3.80%) ▼|GS936.36-13.13 (-1.38%) ▼|HD296.72-8.63 (-2.83%) ▼|HON212.57+0.72 (+0.34%) ▲|IBM232.76+1.38 (+0.60%) ▲|INTC122.60-1.26 (-1.02%) ▼|INTU286.80-5.55 (-1.90%) ▼|ISRG398.30-3.79 (-0.94%) ▼|JNJ269.17-0.02 (-0.01%) ▼|JPM337.53-2.47 (-0.73%) ▼|KO88.09-0.52 (-0.59%) ▼|LIN469.72+4.81 (+1.03%) ▲|LLY1,150.99-19.15 (-1.64%) ▼|LMT524.68+2.34 (+0.45%) ▲|LOW191.36-4.72 (-2.41%) ▼|LRCX307.28-3.35 (-1.08%) ▼|MA559.92+4.03 (+0.73%) ▲|MCD238.32-12.03 (-4.81%) ▼|MDLZ61.44+0.36 (+0.59%) ▲|MDT89.30-1.47 (-1.62%) ▼|META744.10+7.51 (+1.02%) ▲|MMM170.30+1.00 (+0.59%) ▲|MO68.95+0.31 (+0.45%) ▲|MRK148.08-2.83 (-1.88%) ▼|MS198.39-1.79 (-0.89%) ▼|MSFT500.59+2.59 (+0.52%) ▲|MU1,071.88-24.28 (-2.22%) ▼|NEE77.02-2.24 (-2.83%) ▼|NFLX71.36-0.80 (-1.11%) ▼|NKE36.05-0.05 (-0.14%) ▼|NOW140.78+3.78 (+2.76%) ▲|NVDA225.51-3.36 (-1.47%) ▼|ORCL144.56-4.64 (-3.11%) ▼|PEP130.18-1.01 (-0.77%) ▼|PFE28.18+0.25 (+0.90%) ▲|PG147.39-0.83 (-0.56%) ▼|PLTR191.79+6.80 (+3.68%) ▲|PM190.84+0.61 (+0.32%) ▲|QCOM197.24-1.03 (-0.52%) ▼|RTX192.19+1.20 (+0.63%) ▲|SBUX94.14-0.97 (-1.02%) ▼|SCHW99.50-0.85 (-0.85%) ▼|SO83.47-1.68 (-1.97%) ▼|SPG204.16-1.79 (-0.87%) ▼|T25.30+0.20 (+0.80%) ▲|TMO665.30+6.78 (+1.03%) ▲|TMUS165.66+3.25 (+2.00%) ▲|TSLA380.12+1.22 (+0.32%) ▲|TXN272.62+1.21 (+0.45%) ▲|UBER69.42-0.47 (-0.67%) ▼|UNH371.29-1.66 (-0.45%) ▼|UNP275.53+1.12 (+0.41%) ▲|UPS95.82-0.05 (-0.05%) ▼|USB58.48-0.96 (-1.62%) ▼|V361.52-0.52 (-0.14%) ▼|VZ46.52+0.07 (+0.15%) ▲|WFC81.90-1.25 (-1.50%) ▼|WMT110.53+0.41 (+0.37%) ▲|XOM161.23+2.52 (+1.59%) ▲|
17.2 C
New York
Thursday, September 24, 2026

Tag: company

newssourceFORcompanyinformationcontent1releasesmarket

Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio

Ji'an, Jiangxi, China, June 26, 2026 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company has entered into a share purchase agreement to acquire 100% of the issued shares of Best Praise International Limited (“Best Praise”), a company that holds five patents in China with potential applications in pharmaceutical development, for a total purchase price of US$10,751,000, payable in the form of 4,376,552 Class A ordinary shares of the Company.

Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of...

WILMETTE, Ill., June 26, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced that new analyses from the Phase 3 FoCus randomized controlled clinical trial of ALXN1840 (tiomolibdate choline, TMC) will be presented at the 12th Congress of the European Academy of Neurology (EAN 2026), June 27–30, 2026, in Geneva, Switzerland. These analyses build upon the previously reported Phase 3 FoCus results demonstrating ALXN1840 met its primary endpoint of superior copper mobilization versus standard of care.

RATHDOWNEY: ANNOUNCES CLOSING OF FIRST TRANCHE OF PRIVATE PLACEMENT FINANCING

VANCOUVER, BC, June 26, 2026 /CNW/ - Rathdowney Resources Ltd. (TSXV: RTH) ("Rathdowney" or the "Company") is pleased to announce, further to its press release...

Ascendis Joins Multiple Russell U.S. Indexes, Including the Russell 3000®, Russell 1000®, Russell 2500® and Russell Midcap®

COPENHAGEN, Denmark, June 26, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the Company has been added to the broad-market Russell 3000® Index, the large-cap Russell 1000® Index, the small-to-mid-cap Russell 2500® Index, and the Russell Midcap® Index as a part of the 2026 Russell U.S. Indexes semi-annual reconstitution, effective at the close of U.S. equity markets on June 26, 2026.

Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)

BEDFORD, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for LNTH-2501 (Gallium 68 edotreotide), a PET diagnostic imaging kit targeting somatostatin receptor-positive (SSTR+) neuroendocrine tumors (NETs). 

AES Stockholders Approve Acquisition by Global Infrastructure Partners and EQT-Led Consortium

ARLINGTON, Va., June 26, 2026 /PRNewswire/ -- The AES Corporation (the "Company" or "AES") (NYSE: AES) today announced that its stockholders voted to approve...

Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)

STOCKHOLM, June 26, 2026 /PRNewswire/ --The FDA has requested additional data related to chemistry, manufacturing, and controls (CMC) and contract manufacturing facilities; no clinical...

Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)

STOCKHOLM, June 26, 2026 /PRNewswire/ --The FDA has requested additional data related to chemistry, manufacturing, and controls (CMC) and contract manufacturing facilities; no clinical...

PFSI Investor News: If You Have Suffered Losses in PennyMac Financial Services, Inc. (NYSE: PFSI), You Are Encouraged to Contact The Rosen Law Firm...

NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of PennyMac Financial Services, Inc. (NYSE: PFSI) resulting from allegations that PennyMac may have issued materially misleading business information to the investing public.

Eldorado Completes Acquisition of Vantage Drilling International Ltd., Creating a Scaleable Offshore Drilling Platform with Enhanced Capabilities

Dubai, June 26, 2026 (GLOBE NEWSWIRE) -- Eldorado Drilling Limited (“Eldorado”) and Vantage Drilling International Ltd. (“Vantage”) today announced the completion of Eldorado’s acquisition of Vantage by merger, pursuant to which an indirect subsidiary of Eldorado merged with and into Vantage, with Vantage surviving as an indirect subsidiary of Eldorado as of 3.00 p.m. Bermuda time on June 26, 2026 (the “Closing”).

Rocket Lab Completes 10th Consecutive Launch with 100% Mission Success for Synspective

MAHIA, New Zealand, June 26, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB), a global leader in launch services and space systems, today announced it has successfully placed another satellite into orbit for Synspective, achieving a significant milestone as the tenth dedicated launch for the Japan-based Earth observation company with 100% mission success.

Revision Skincare® Appoints Marco Ficarelli as Chief Global Growth Officer

DALLAS, June 26, 2026 /PRNewswire/ -- Revision Skincare®, a physician-dispensed, clinically validated skincare brand focused on long-term skin health and medical-grade skincare for everyday use,...

Curaleaf to Report Second Quarter 2026 Financial and Operational Results

STAMFORD, Conn., June 26, 2026 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of...

After more than four decades of exceptional leadership and contribution to the fragrance industry, we announce the retirement of Jack Corley, Chief Sales and...

SOMERSET, N.J. , June 26, 2026 /PRNewswire/ -- Jack's career spans 45 years and is marked by a rare combination of commercial excellence, industry expertise,...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCompany

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers